SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-349308
Filing Date
2012-08-10
Accepted
2012-08-10 12:16:07
Documents
11
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d331069d10q.htm 10-Q 589933
2 EX-31.1 d331069dex311.htm EX-31.1 8328
3 EX-31.2 d331069dex312.htm EX-31.2 8315
4 EX-32.1 d331069dex321.htm EX-32.1 3214
5 EX-32.2 d331069dex322.htm EX-32.2 3167
  Complete submission text file 0001193125-12-349308.txt   3187862

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT clvs-20120630.xml EX-101.INS 369359
7 XBRL TAXONOMY EXTENSION SCHEMA clvs-20120630.xsd EX-101.SCH 35501
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE clvs-20120630_cal.xml EX-101.CAL 41721
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE clvs-20120630_def.xml EX-101.DEF 97763
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE clvs-20120630_lab.xml EX-101.LAB 258052
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clvs-20120630_pre.xml EX-101.PRE 181911
Mailing Address 2525 28TH STREET SUITE 100 BOULDER CO 80301
Business Address 2525 28TH STREET SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Filer) CIK: 0001466301 (see all company filings)

IRS No.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35347 | Film No.: 121023533
SIC: 2834 Pharmaceutical Preparations